Dr. Naga Rajiv Lakkaniga's Research Group
2024
13) Masters students' thesis presentaion
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
12) Congratulations Anubhav on your first publication!
https://doi.org/10.1039/D4MD00003J
​
11) Dr. Sunil Dubey, General Manager, Medical R&D, Emami visits the lab.
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
10) Congratulations Amrita on your first publication!
https://doi.org/10.1002/ptr.8187
​
9) Samreen, Shashi, Sushmita and Shubham join the group for Masters dissertation. Welcome all!
​
2023 and older
​
8) How does limiting conformational flexibility of small molecules kinase inhibitors improve the selectivity?
Check out our latest article in RSC Medicinal Chemistry!
https://doi.org/10.1039/D3MD00457K
​
7) Publication alert!
Lakkaniga, N.R. et al. Revisiting Aurora Kinase B: A promising therapeutic target for cancer therapy. Medicinal Research Reviews. https://doi.org/10.1002/med.21994
IF: 13.3
​
6) Anubhav Rai joins the group. welcome Anubhav!
​
5) Publication alert!
Sharma, P.D., Rallapalli, S. & Lakkaniga, N.R. An innovative approach for predicting pandemic hotspots in complex wastewater networks using graph theory coupled with fuzzy logic. Stoch Environ Res Risk Assess (2023). https://doi.org/10.1007/s00477-023-02468-3
​
4) Congratulations Ayub for your placement!
​
3) Anuradha Singh joins the group. Welcome Anuradha!
​
2) Received SERB- Start-up research grant!
​
1) New publication in RSC Medicinal Chemistry:
Acharya, B., Saha, D., Armstrong, D., Lakkaniga, N.R. and Frett, B., 2022. FLT3 Inhibitors for Acute Myeloid Leukemia: Successes, Defeats, and Emerging Paradigms. RSC Medicinal Chemistry 2022, 13, 798